Last reviewed · How we verify
NCT06645041
The Impact of Vitamin D Supplementation in Hypertensive Vitamin D Deficient Patients.
NA trial testing Vitamin D (Cholecalciferol ) in Hypertension in 60 participants. Completed in 13 August 2025.
13 August 2025
Quick facts
| Lead sponsor | University of Sulaimani |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 16 November 2024 |
| Primary completion | 13 August 2025 |
| Estimated completion | 13 August 2025 |
| Sites | 3 locations across Iraq |
Drugs / interventions tested
- Vitamin D (Cholecalciferol ) — full drug profile →
- Placebo Capsule(s)
Conditions studied
- Hypertension — all drugs for Hypertension →
- Vitamin D Deficiency — all drugs for Vitamin D Deficiency →
Sponsor
University of Sulaimani
Who can join
Adults 40 to 65, any sex, with Hypertension or Vitamin D Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will assess the impact of Vitamin D supplementation on hypertensive patients with Vitamin D deficiency, it will also investigate the relationship between serum Vitamin D, irisin levels, blood pressure, and heart rate variability (HRV) in hypertensive and normotensive individuals. It is hypothesized that a decrease in blood pressure and an increase in HRV will be noted in the hypertensive treatment group (subjects on supplemental vitamin D) in comparison to the hypertensive control group (placebo) upon vitamin D supplementation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06645041
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vitamin D (Cholecalciferol )
Trials testing the same drug.
- NCT06610968 — Acute Vitamin D Supplementation on Testosterone in Females · NA · active not recruiting
- NCT07167797 — Evaluation of the Role of Vitamin D in Reducing the Severity and Duration of Rotavirus Infection in Iraqi Children · NA · completed
- NCT06919718 — Impact of Vitamin D Supplements on Mental Health and Milk Composition in Mothers Living in Idaho · NA · recruiting
- NCT06596122 — Vitamin D Supplementation in Breast Cancer Patients · Phase 2 · not yet recruiting
- NCT07229456 — Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion · Phase 3 · active not recruiting
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other University of Sulaimani trials
Trials by the same sponsor.
- NCT07234149 — Tooth Discoloration and Chairside Handling Time (Bonding-Debonding) in Flowable Versus Packable Composites for Clear Ali · NA · recruiting
- NCT07142525 — Hybrid Osteoplasty Versus Osteotomy in Rhinoplasty · NA · not yet recruiting
- NCT06719674 — Diode Laser as an Adjunct to Professional Mechanical Plaque Removal · NA · recruiting
- NCT06719661 — The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes · NA · completed
- NCT06968754 — The Impact of Pharmaceutical Care on the Infection Control Measures Among Hemodialytic Patients · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06645041 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sulaimani
- Last refreshed: 15 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06645041.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing